| 1 | Total | 1.63% | |
| 2 | HIV | 1.63% | |
| 3 | Pain | 1.63% | |
| 4 | University | 0.81% | |
| 5 | LGBTQ | 0.81% | |
| 6 | Childhood | 0.81% | |
| 7 | Testing | 0.81% | |
| 8 | Reduce | 0.81% | |
| 9 | Women’s | 0.81% | |
| 10 | Tumors | 0.81% | |
| 11 | Cryotherapy | 0.81% | |
| 12 | Allergy | 0.81% | |
| 13 | $1B | 0.81% | |
| 14 | Cefazolin | 0.81% | |
| 15 | Proteins | 0.81% | |
| 16 | Risk | 0.81% | |
| 17 | Vaccine | 0.81% | |
| 18 | Africa’s | 0.81% | |
| 19 | Study | 0.81% | |
| 20 | Fibrosis | 0.81% | |
| 21 | Age | 0.81% | |
| 22 | Emphysema | 0.81% | |
| 23 | Fight | 0.81% | |
| 24 | Overlapping | 0.81% | |
| 25 | Atypical | 0.81% | |
| 26 | Pneumonia | 0.81% | |
| 27 | Pharmacogenomics | 0.81% | |
| 28 | Transcatheter | 0.81% | |
| 29 | Prevalence | 0.81% | |
| 30 | Safe | 0.81% | |
| 31 | Outcomes | 0.81% | |
| 32 | Doubling | 0.81% | |
| 33 | Eosinophilic | 0.81% | |
| 34 | UB | 0.81% | |
| 35 | Integration | 0.81% | |
| 36 | Relieved | 0.81% | |
| 37 | JAA | 0.81% | |
| 38 | Stymieing | 0.81% | |
| 39 | OB/GYN | 0.81% | |
| 40 | Meds | 0.81% | |
| 41 | Reducing | 0.81% | |
| 42 | Favor | 0.81% | |
| 43 | Youth | 0.81% | |
| 44 | Gastroesophageal | 0.81% | |
| 45 | POZ | 0.81% | |
| 46 | Poxvirus | 0.81% | |
| 47 | Gastric | 0.81% | |
| 48 | An | 0.81% | |
| 49 | Sri | 0.81% | |
| 50 | Marathon | 0.81% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||